-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on Boston Scientific, Lowers Price Target to $56

Benzinga·07/30/2026 15:47:01
语音播报
TD Cowen analyst Joshua Jennings maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price target from $61 to $56.